Antibodies

DHS reports first two Wisconsin child deaths from RSV this season | Local News

by
DHS reports first two Wisconsin child deaths from RSV this season | Local News

State AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWashington D.C.West VirginiaWisconsinWyomingPuerto RicoUS Virgin IslandsArmed Forces AmericasArmed Forces PacificArmed Forces EuropeNorthern Mariana IslandsMarshall IslandsAmerican SamoaFederated States of MicronesiaGuamPalauAlberta, CanadaBritish Columbia, CanadaManitoba, CanadaNew Brunswick, CanadaNewfoundland, CanadaNova Scotia, CanadaNorthwest Territories, CanadaNunavut, CanadaOntario, CanadaPrince Edward Island, CanadaQuebec, CanadaSaskatchewan, CanadaYukon Territory, Canada Zip Code Country United States of … Read more

XBB.1.5 vaccine booster shows promise against new Omicron variants in latest study

by
XBB.1.5 vaccine booster shows promise against new Omicron variants in latest study

In a recent study posted to bioRxiv preprint* server, researchers observed that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) XBB.1.5 monovalent vaccine booster induces robust neutralizing antibodies (nAbs) against emergent variants.  SARS-CoV-2 Omicron XBB sub-variants have reduced the effectiveness of current vaccines, leading to the authorization of monovalent XBB.1.5 vaccines. While preliminary evidence suggests that … Read more

Andrew Buchanan’s Impact on Biologics Innovation

by
Andrew Buchanan’s Impact on Biologics Innovation

Following ELRIGs Drug Discovery Conference, News Medical took part in an insightful discussion with Dr. Andrew Buchanan, a renowned figure in the realm of biopharmaceutical research. Dr. Buchanan’s career spans 22 years, notably at Cambridge Antibody Technology, MedImmune, and AstraZeneca, where he has significantly contributed to the development of 18 antibody-based drugs, including three successful … Read more

New classification criteria for antiphospholipid syndrome

by
New classification criteria for antiphospholipid syndrome

APS is a systemic autoimmune disease associated with persistent antiphospholipid antibodies (aPL). It can cause thrombosis and pregnancy complications as well as non-thrombotic manifestations such as cardiac valve disease. Classification is important to help identify people to take part in research and ensures that similar disease states are included and compared in trials. This is … Read more

A game-changer in early detection and management of type 1 diabetes

by
A game-changer in early detection and management of type 1 diabetes

The latest data on universal screening for type 1 diabetes (T1D) is reviewed in a session at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 October). The talk will be given by Dr. Emily K. Sims, Associate Professor of Pediatrics, Center for Diabetes and Metabolic … Read more